Delivery Order SPE2DB22D2211-SPE2DB24FNES2
- Not listed
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract, valued at $44,257.26, is for the supply of 4,564,110,324 units of the pharmaceutical product DUPIXENT 300 MG/2 ML SYRINGE 2ML. The delivery order has a ceiling value of $44,257.26 and a period of performance through March 29, 2024. Amerisourcebergen Drug Corp is the prime contractor on this...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the supply of DUPIXENT 300 MG/2 ML SYRINGE 2ML, a pharmaceutical product, with a ceiling value of $18,699.59 and a period of performance through April 8, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued up to $999,999,999, which serves as the...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,523.76, is for the supply of DUPIXENT 300 MG/2 ML SYRINGE 2ML, a specialty pharmaceutical product. The order has a completion date of February 7, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This is a firm fixed price delivery order issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of the pharmaceutical product DUPIXENT 300 MG/2 ML PEN 2ML. The contract has a ceiling value of $10,141.32 and a performance period through April 9, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31, 2025,...
- This is a $14,871.15 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of DUPIXENT 300 MG/2 ML SYRINGE 2ML, a specialty pharmaceutical product, with a period of performance through October 2023. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The $7,184.38 firm fixed price contract is for the supply of DUPIXENT 300 MG/2 ML SYRINGE 2ML pharmaceuticals, with a period of performance through March 15, 2024. Amerisourcebergen Drug Corp is the prime contractor on a $999,999,999.00 indefinite delivery contract (IDC) with DLA Troop Support Medical, which serves...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of DUPIXENT 300 MG/2 ML SYRINGE 2ML. The contract has a ceiling value of $13,121.78 and a period of performance through September 5, 2024. This is a firm-fixed-price contract with no set-aside designation. Amerisourcebergen has been awarded multiple federal contracts and indefinite delivery contracts (IDCs) by various...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The order is for the pharmaceutical product DUPIXENT 300 MG/2 ML PEN 2ML, with a potential value of $4,974.84 and a completion date of February 15, 2024. Amerisourcebergen Drug Corp, as a prime contractor, provides a wide range of pharmaceutical products and medical supplies to U.S. government agencies,...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of DUPIXENT 300 MG/2 ML SYRINGE 2ML, a pharmaceutical product, with a ceiling value of $23,789.52 and a period of performance ending on May 19, 2025. The contract is not set aside and represents an open competition. Amerisourcebergen Drug Corp holds a significant Indefinite...
- This is a $38,452.80 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for DUPIXENT 300 MG/2 ML SYRINGE 2ML. The award has an ultimate completion date of November 26, 2024. AmerisourceBergen, a major pharmaceutical distributor, holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products...
- SPE2DB22D2211Indefinite Delivery Contract
- SPE2DB22D2211-SPE2DB24FNES2Delivery Order
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The order is for the pharmaceutical product DUPIXENT 300 MG/2 ML SYRINGE 2ML, with a ceiling value of $7,263.57 and a period of performance through April 15, 2024. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to provide pharmaceuticals and medical supplies to support military treatment programs and facilities worldwide. This delivery order was issued under that IDC on a sole source basis, with no set-aside designation. Amerisourcebergen Corporation, the parent company of the prime contractor, is also an established federal contractor that provides medical products and services to government agencies.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.3k | 4/12/24 |